Partner Headlines - IRWD

  1. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  4. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  5. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  6. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  7. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  8. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  9. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  10. Stocks Hitting 52-Week Lows

    Benzinga
  11. Earnings Scheduled For January 15, 2013

    Benzinga
  12. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  13. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  14. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  15. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  16. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  17. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  18. Biotechs With Upcoming PDUFA Dates

    Benzinga
  19. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  20. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  21. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  22. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  23. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  24. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  25. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center